Huaizhong Health Group, Inc. (ADAD)
USD 0.11
(0.0%)
USD 0.11
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -30.57 Thousand | -31.79 Thousand | 36.48 | -14.95 Thousand | -559.00 | -1134.00 |
| Net Income | -29.17 Thousand | -30.82 Thousand | -36.48 Thousand | -126.09 Thousand | -6368.00 | -1134.00 |
| Depreciation & Amortization | - | - | - | - | 526.00 | - |
| Deferred income taxes | - | - | - | - | - | -3894.00 |
| Stock-based compensation | - | - | - | 100 Thousand | - | - |
| Change in working capital | -1400.00 | 30.82 Thousand | 36.48 Thousand | 11.14 Thousand | 5809.00 | -3894.00 |
| Other non-cash items | -0.15 | -31.79 Thousand | 36.48 | -88.86 | 6943.00 | 7788.00 |
| Investing Cash Flow | - | - | - | - | 526.00 | 852.00 |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | 526.00 | 852.00 |
| Financing Cash Flow | 30.57 Thousand | 31.79 Thousand | 31 Thousand | 14.95 Thousand | - | - |
| Debt repayment | -30.57 Thousand | - | - | -14.95 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 31 Thousand | - | - | - |
| Other Financing Activities | 30.57 Thousand | 31.79 Thousand | -31 Thousand | 29.91 Thousand | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -150.00 | -963.00 | 251.00 | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -1250.00 | 31.79 Thousand | 36.22 Thousand | 11.14 Thousand | -1134.00 | -3894.00 |
| Cash at beginning of period | - | - | -36.48 | - | 33.00 | 315.00 |
| Cash at end of period | - | - | 31 Thousand | - | 33.00 | 33.00 |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | 31.03 Thousand | - | - | -282.00 |
| Free Cash Flow | -30.57 Thousand | -31.79 Thousand | 36.48 | -14.95 Thousand | -559.00 | -1134.00 |
| Breakdown | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | - | - | -10.55 Thousand | -29.17 Thousand | -7346.00 |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | 10.55 Thousand | -1400.00 | -23.22 Thousand |
| Other non-cash items | - | - | - | -10.55 Thousand | -0.15 | -0.65 |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | - | - | - | 30.57 Thousand | 30.57 Thousand |
| Debt repayment | - | - | - | - | -30.57 Thousand | -2496.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | 30.57 Thousand | 33.06 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | 9800.00 | -150.00 | 450.00 |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | -9800.00 | -1250.00 | -23.67 Thousand |
| Cash at beginning of period | - | - | - | - | - | - |
| Cash at end of period | - | - | - | -10.55 Thousand | - | - |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | - | -10.55 Thousand | - | - |
| Free Cash Flow | - | - | - | -10.55 Thousand | -30.57 Thousand | -30.57 Thousand |
CMO
CHIF
2316
BMTX
NAHD
MEDC